Endomines’ Share Traded without the Unit Right from November 5
The subscription price is SEK 1.10 per unit for subscription in Sweden. Subscription in Finland is in euro and the subscription price will be determined based on Sveriges Riksbank’s official EUR/SEK exchange rate the day before the prospectus is approved by the SFSA.
The prospectus is expected to be approved no later than Friday, November 7, 2014.
Endomines AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08:45 CET on September 30, 2014.
About Endomines AB
Endomines is conducting exploration as well as mining activities along the 40 kilometer extended Karelian Gold Line. Endomines is controlling, based on decisions from relevant authorities, the exploration rights for the entire area.
The Company´s first mine, Pampalo, was started in February 2011. During 2014 production from the open pit at Rämepuro was commenced and the Company is now planning to start mining of the gold deposit at Hosko. The ore from Hosko, as for Rämepuro ore, will be treated at Pampalo mill, at the center of the Karelian Gold Line.
The Company operates under a regime of sustainable principles and with a business practice to minimize the impact to the environment.
Endomines applies SveMin's & FinnMin's respective rules for reporting (public mining & exploration companies). The Company has chosen to report mineral resources and ore reserves according to the JORC-code, which is the internationally accepted Australasian code for reporting ore reserves and mineral resources.
Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise.
The shares of Endomines AB are quoted on NASDAQ Stockholm under ticker ENDO and on NASDAQ Helsinki under ticker ENDOM. Pareto Securities acts as Liquidity Provider in Stockholm.
Important information
Publication or distribution of this press release in certain jurisdictions may be restricted by law and persons in those jurisdictions where this press release is published or distributed should inform themselves about and observe such restrictions.
This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Hong Kong, Japan, Singapore, South Africa or New Zealand or any other country where such action is wholly or partially subject to legal restrictions. The information in this press release may not be forwarded, reproduced or disclosed in ways that conflict with such restrictions. Omission to follow this instruction may result in violation of the United States Securities Act of 1933 ("Securities Act"), as amended, or applicable laws of other jurisdictions.
This press release does not constitute an invitation or offer to acquire, subscribe for or otherwise trade in unit rights, interim shares, interim units, new shares or warrants in Endomines AB (publ). An invitation for interested persons to subscribe for Units in Endomines AB (publ) will only be made through the prospectus that Endomines AB (publ) intends to publish on or about November 3, 2014. Neither the unit rights, paid subscribed shares, interim units, new shares or warrants will be registered under the Securities Act, or under the securities laws of any state of the United States or any province in Canada and may not be offered or sold in the United States or Canada or to a resident there or on behalf of such persons other than in such exceptional cases that do not require registration under the Securities Act or any provincial act in Canada.
In case of differences between the Swedish and English language versions of this press release, the Swedish language version shall prevail.
This information was brought to you by Cision http://news.cision.com
Contacts
Endomines
Markus Ekberg CEO
Phone +358-40-706 48 50
www.endomines.com